Camber Recalls Acyclovir Tablets Due to Foreign Substance
Camber Pharmaceuticals recalls 13,692 bottles of Acyclovir 800 mg tablets due to human hair found in the product. Check your lot number.
Stop using this now
Presence of Foreign Substance: human hair melded into tablet.
Contact the company
What happened, in plain English
Camber Pharmaceuticals is recalling 13,692 bottles of Acyclovir Tablets, USP, 800 mg because human hair was found melded into the tablets. The affected bottles were distributed nationwide and are prescription-only. The record does not specify a remedy or deadline for consumers. Read more at govinfonow.com/recall/41637-camber-recalls-acyclovir-tablets-due-to-foreign-substance.
Source Summary by GovInfoNow · govinfonow.com/recall/41637-camber-recalls-acyclovir-tablets-due-to-foreign-substance · Updated October 11, 2026 · FDA enforcement record: FDA #D-0897-2017
Cite this page
“Camber Recalls Acyclovir Tablets Due to Foreign Substance.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41637-camber-recalls-acyclovir-tablets-due-to-foreign-substance. Based on FDA recall #D-0897-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0897-2017%22&limit=1).
Why it’s dangerous
The recall is due to the presence of a foreign substance, specifically human hair melded into the tablet. Ingesting such material poses a contamination risk, although the record does not detail specific injuries resulting from consumption.
Who’s affected
Consumers who purchased Acyclovir Tablets, USP, 800 mg in 100-count bottles from anywhere in the United States. Individuals taking this specific prescription medication are at risk of ingesting a foreign substance.
How to tell if you have this one
Check your bottle for Acyclovir Tablets, USP, 800 mg, manufactured by Hetero Labs Limited for Camber Pharmaceuticals, Inc. Look for NDC 31722-778-01 and Lot # ACY16075 with an expiration date of 09/2018.
- Brand
Camber Pharmaceuticals- Category
Drug
What to do — step by step
Stop taking the medication
Do not consume any tablets from the recalled lot due to the presence of human hair.
Check your lot number
Verify if your bottle has Lot # ACY16075 and an expiration date of 09/2018.
Contact your pharmacist
Speak with your healthcare provider or pharmacist to discuss alternative treatment options since the record does not list a return or replacement process.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many bottles are being recalled?
A total of 13,692 bottles are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0897-2017 (April 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0897-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.